deltatrials
Recruiting PHASE4 INTERVENTIONAL 3-arm NCT04974151

China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype (CSPPT2-TT)

Comparative Efficacy of Amlodipine Folic Acid vs. Amlodipine on the Risk of First Ischemic Stroke Among Participants With Hypertension and MTHFR 677 TT Genotype: A Multi-center, Randomized, Double-blind, Triple-dummy, Controlled Clinical Trial

Sponsor: Bozhou people's hospital

Updated 7 times since 2021 Last updated: Feb 24, 2025 Started: Aug 22, 2024 Primary completion: Jun 30, 2029 Completion: Jun 30, 2029
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Hypertension and MTHFR 677 TT Genotype, this trial is actively recruiting participants. The trial is conducted by Bozhou people's hospital and has accumulated 7 data snapshots since 2024. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

~Sep 2021 – ~May 2022 · 8 months · monthly snapshotNot Yet Recruiting~May 2022 – ~Jul 2024 · 26 months · monthly snapshotNot Yet Recruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Nov 2024 · 2 months · monthly snapshot~Nov 2024 – ~Mar 2025 · 4 months · monthly snapshot~Mar 2025 – ~Jun 2025 · 3 months · monthly snapshot~Jun 2025 – present · 15 months · monthly snapshotRecruiting

Change History

7 versions recorded
  1. Jun 2025 — Present [monthly]

    Recruiting PHASE4

  2. Mar 2025 — Jun 2025 [monthly]

    Recruiting PHASE4

  3. Nov 2024 — Mar 2025 [monthly]

    Recruiting PHASE4

    Status: Not Yet RecruitingRecruiting

  4. Sep 2024 — Nov 2024 [monthly]

    Not Yet Recruiting PHASE4

  5. Jul 2024 — Sep 2024 [monthly]

    Not Yet Recruiting PHASE4

Show 2 earlier versions
  1. May 2022 — Jul 2024 [monthly]

    Not Yet Recruiting PHASE4

  2. Sep 2021 — May 2022 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Bozhou people's hospital
  • Chengdu Fifth People's Hospital
  • Chizhou people's hospital
  • Deyang People's Hospital
  • First Affiliated Hospital of Gannan Medical University
  • Lianyungang Oriental Hospital
  • Lianyungang Second People's Hospital
  • Loudi Central Hospital
  • Peking University First Hospital
  • Second Affiliated Hospital of Nanchang University
  • Shenzhen Ausa Pharmed Co.,Ltd
  • Shenzhen Prospective Medical Technology Co., LTD
  • TAIHE country people's hospital
  • Tengzhou Central People's Hospital
  • The Affiliated Hospital Of Guizhou Medical University
  • The Affiliated Hospital Of Southwest Medical University
  • The First Affiliated Hospital of Bengbu Medical University
  • The First Affiliated Hospital of HuNan University of Medicine
  • The First People's Hospital of Lianyungang
  • Weinan Central Hospital
  • Yancheng First People's Hospital
  • Yangjiang People's Hospital
Data source: Shenzhen Ausa Pharmed Co.,Ltd

For direct contact, visit the study record on ClinicalTrials.gov .